Dissecting Hedgehog, TGF beta and BMP Signaling During Pancreatic Tumorigenesis

剖析胰腺肿瘤发生过程中的 Hedgehog、TGF beta 和 BMP 信号传导

基本信息

  • 批准号:
    8254393
  • 负责人:
  • 金额:
    $ 33.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-08 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Pancreatic cancer is a leading cause of cancer-related mortality in the United States, with an estimated 35,000 people dying from this disease in 2009. Activating mutations in the KRAS2 oncogene occur in >90% of pancreatic ductal adenocarcinomas (PDAC), the most common type of pancreatic cancer, and are believed to be initiating lesions in PDAC. Elevated levels of hedgehog pathway components are found in a majority of PDAC specimens and cell lines. Loss of the Smad4 transcriptional regulator occurs in approximately half of PDAC cases, and inactivation of the TGF?RII, BMPRII, and ALK4 receptor kinases that act upstream of Smad4 occurs in a smaller subset of PDAC cases. Yet, the precise roles of the hedgehog pathway and the signaling pathways activated by TGF-? family ligands in PDAC remain unclear. This application therefore proposes to use a novel mouse modeling system and complementary cell culture and in vitro studies to systematically investigate the roles of these pathways in pancreatic carcinogenesis. Prior studies have provided conflicting data on whether hedgehog ligands act in both autocrine and paracrine fashion, or only a paracrine manner, during pancreatic tumor development. Therefore, studies in Aim 1 will use novel mouse models to directly compare the ability of sonic hedgehog (Shh) and its downstream transcription factors Gli1 and Gli2 to cooperate with activated Kras during pancreatic tumorigenesis in vivo. Analyses of tumor samples and cell lines generated from the tumors induced in this Aim will be performed to determine whether Shh stimulates signaling in both the cancer cells and the reactive stroma, or only within the reactive stroma. Finally, using a novel dominant-repressor Gli3 allele, the requirement for Gli transcription activity in Kras-induced pancreatic tumorigenesis will be determined. The studies in Aim 2 will identify the relative contributions of defects in TGF-? and BMP signaling to pancreatic tumorigenesis. ShRNAs targeting Smad4, TGF?RII, or BMPRII will be delivered specifically to the pancreatic epithelium in vivo, and their ability to cooperate with activated Kras determined. Complementary experiments in cancer cell lines derived from the induced tumors will be performed to determine whether defects in TGF-( or BMP signaling alter the phenotypes of pancreatic cancer cells, and how TGF-( family ligands influence pancreatic cancer cell behavior. The studies in Aim 3 will determine whether there is cross-talk between the hedgehog and TGF-( signaling cascades in pancreatic cancer cells, and how this cross-talk influences the phenotypes of these cells. Finally, gene expression profiling will be used to identify important genes downstream of the hedgehog and TGF-( signaling cascades. The biological importance of these genes during pancreatic tumorigenesis will be validated using studies of the cancer cell lines generated in Aims 1 and 2, and the ability of these genes to cooperate with activated Kras during pancreatic tumorigenesis in vivo. PUBLIC HEALTH RELEVANCE: Pancreatic cancer claims the lives of 35,000 Americans annually; therefore understanding the mechanisms that contribute to the initiation and progression of this disease is of great significance. Through the use of novel mouse models for pancreatic cancer, this application seeks to understand how alterations in the hedgehog, transforming growth factor beta, and bone morphogenic protein signaling pathways contribute to pancreatic cancer initiation and progression. These studies will significantly enhance the understanding of pancreatic cancer, and may lead to the development of novel therapeutic strategies, thereby reducing the impact of this disease on public health.
描述(由申请人提供):胰腺癌是美国癌症相关死亡率的主要原因,2009年估计有35,000人死于该疾病。KRAS 2癌基因的激活突变发生在>90%的胰腺导管腺癌(PDAC)(最常见的胰腺癌类型)中,并且被认为是PDAC中的起始病变。在大多数PDAC标本和细胞系中发现hedgehog途径组分水平升高。Smad 4转录调节因子的丢失发生在大约一半的PDAC病例中,TGF?RII、BMPRII和ALK 4受体激酶作用于Smad 4的上游,出现在PDAC病例的较小子集中。然而,刺猬通路和TGF-β激活的信号通路的确切作用?PDAC中的家族配体仍不清楚。因此,本申请提出使用新的小鼠建模系统和互补的细胞培养和体外研究来系统地研究这些途径在胰腺癌发生中的作用。 先前的研究提供了相互矛盾的数据,刺猬配体是否自分泌和旁分泌的方式,或仅旁分泌的方式,在胰腺肿瘤的发展。因此,目标1中的研究将使用新型小鼠模型直接比较音刺猬(Shh)及其下游转录因子Gli 1和Gli 2在体内胰腺肿瘤发生期间与活化的Kras合作的能力。将对肿瘤样品和由在该目的中诱导的肿瘤产生的细胞系进行分析,以确定Shh是否刺激癌细胞和反应性基质两者中的信号传导,或仅刺激反应性基质内的信号传导。最后,使用一种新的显性阻遏物Gli 3等位基因,将确定在Kras诱导的胰腺肿瘤发生中对Gli转录活性的需求。 目标2中的研究将确定TGF-β 1缺陷的相对贡献。和BMP信号传导到胰腺肿瘤发生。靶向Smad 4、TGF?RII或BMPRII将在体内特异性地递送至胰腺上皮,并且确定它们与活化的Kras合作的能力。将在源自诱导肿瘤的癌细胞系中进行补充实验以确定TGF-β或BMP信号传导的缺陷是否改变胰腺癌细胞的表型,以及TGF-β家族配体如何影响胰腺癌细胞行为。 目标3中的研究将确定胰腺癌细胞中hedgehog和TGF-β信号级联之间是否存在串扰,以及这种串扰如何影响这些细胞的表型。最后,基因表达谱将用于鉴定hedgehog和TGF-β信号级联下游的重要基因。这些基因在胰腺肿瘤发生过程中的生物学重要性将使用目的1和2中产生的癌细胞系的研究以及这些基因在体内胰腺肿瘤发生过程中与活化的Kras合作的能力来验证。 公共卫生关系:胰腺癌每年夺去35,000名美国人的生命;因此,了解导致这种疾病发生和发展的机制具有重要意义。通过使用胰腺癌的新型小鼠模型,本申请旨在了解刺猬,转化生长因子β和骨形态发生蛋白信号通路的改变如何有助于胰腺癌的发生和进展。这些研究将大大提高对胰腺癌的认识,并可能导致新的治疗策略的发展,从而减少这种疾病对公共卫生的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRIAN C LEWIS其他文献

BRIAN C LEWIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRIAN C LEWIS', 18)}}的其他基金

Targeting MTOR signaling in pancreatic cancer
靶向胰腺癌中的 MTOR 信号传导
  • 批准号:
    10367271
  • 财政年份:
    2022
  • 资助金额:
    $ 33.95万
  • 项目类别:
Targeting MTOR signaling in pancreatic cancer
靶向胰腺癌中的 MTOR 信号传导
  • 批准号:
    10617656
  • 财政年份:
    2022
  • 资助金额:
    $ 33.95万
  • 项目类别:
Impact of circadian disruption on pancreatic cancer development and progression
昼夜节律紊乱对胰腺癌发生和进展的影响
  • 批准号:
    10531625
  • 财政年份:
    2021
  • 资助金额:
    $ 33.95万
  • 项目类别:
Impact of circadian disruption on pancreatic cancer development and progression
昼夜节律紊乱对胰腺癌发生和进展的影响
  • 批准号:
    10373645
  • 财政年份:
    2021
  • 资助金额:
    $ 33.95万
  • 项目类别:
IMSD at the University of Massachusetts Medical School
马萨诸塞大学医学院 IMSD
  • 批准号:
    10553216
  • 财政年份:
    2020
  • 资助金额:
    $ 33.95万
  • 项目类别:
IMSD at the University of Massachusetts Medical School
马萨诸塞大学医学院 IMSD
  • 批准号:
    10093106
  • 财政年份:
    2020
  • 资助金额:
    $ 33.95万
  • 项目类别:
Pathway to graduate study post-baccalaureate training program
研究生学习途径 学士学位后培训计划
  • 批准号:
    10080738
  • 财政年份:
    2018
  • 资助金额:
    $ 33.95万
  • 项目类别:
Pathway to graduate study post-baccalaureate training program
研究生学习途径 学士学位后培训计划
  • 批准号:
    10321902
  • 财政年份:
    2018
  • 资助金额:
    $ 33.95万
  • 项目类别:
Pathway to graduate study post-baccalaureate training program
研究生学习途径 学士学位后培训计划
  • 批准号:
    9416571
  • 财政年份:
    2018
  • 资助金额:
    $ 33.95万
  • 项目类别:
Pathway to graduate study post-baccalaureate training program
研究生学习途径 学士学位后培训计划
  • 批准号:
    10557496
  • 财政年份:
    2018
  • 资助金额:
    $ 33.95万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 33.95万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 33.95万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 33.95万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 33.95万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 33.95万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 33.95万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 33.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 33.95万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 33.95万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 33.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了